[HTML][HTML] Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - dash.harvard.edu
Background: High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Background High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
[HTML][HTML] Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - oncotarget.com
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia
(HGPIN): a systematic review and adjusted indirect treatment... | Oncotarget Online ISSN …
(HGPIN): a systematic review and adjusted indirect treatment... | Oncotarget Online ISSN …
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - europepmc.org
Background High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
[PDF][PDF] Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - trials - pdfs.semanticscholar.org
Background: High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - oncotarget.com
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia
(HGPIN): a systematic review and adjusted indirect treatment... | Oncotarget Online ISSN …
(HGPIN): a systematic review and adjusted indirect treatment... | Oncotarget Online ISSN …
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment …
K Cui, X Li, Y Du, X Tang, S Arai, Y Geng, Y Xi, H Xu… - Oncotarget, 2017 - europepmc.org
Background High-grade prostatic intraepithelial neoplasia (HGPIN) is the precursor or
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …
premalignant form of prostate cancer. At least 30% patients with a confirmed HGPIN will …